Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up

Objective: to study the efficiency and safety of tocilizumab (TCZ) therapy in patients with systemic-onset juvenile idiopathic arthritis (sJIA). Patients and methods. The retrospective study included 48 children with active sJIA in whom TCZ therapy was initiated because of the inefficiency of using...

Descripció completa

Dades bibliogràfiques

Autors principals:	M. M. Kostik, E. A. Isupova, I. A. Chikova, M. F. Dubko, V. V. Masalova, L. S. Snegireva, O. V. Kalashnikova, V. G. Chasnyk
Format:	Artigo
Idioma:	Russo
Publicat:	IMA-PRESS LLC 2018-01-01
Col·lecció:	Современная ревматология
Matèries:	systemic juvenile idiopathic arthritis interleukin-6 tocilizumab remission
Accés en línia:	https://mrj.ima-press.net/mrj/article/view/793
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!